Published in Gastroenterology on February 01, 1973
Biopterin derivatives in human body fluids and tissues. J Clin Pathol (1976) 1.41
Folates in human serum. J Clin Pathol (1974) 1.07
Simulation of Food Folate Digestion and Bioavailability of an Oxidation Product of 5-Methyltetrahydrofolate. Nutrients (2017) 0.75
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
The current and future market for veterinarians and veterinary medical services in the United States. J Am Vet Med Assoc (1999) 9.90
Finding protein similarities with nucleotide sequence databases. Methods Enzymol (1990) 6.63
Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med (1998) 4.38
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70
Translocation as a species conservation tool: status and strategy. Science (1989) 3.31
The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem (1996) 3.26
Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet (1984) 2.85
Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA (2001) 2.70
Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69
Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet (1992) 2.63
Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet (1996) 2.53
Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52
Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol (1997) 2.40
Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.40
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17
Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature (1985) 2.15
Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci U S A (1980) 2.14
A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res (1998) 2.12
Selective inactivation of the transacylase components of the 2-oxo acid dehydrogenase multienzyme complexes of Escherichia coli. Biochem J (1976) 2.10
Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10
Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut (2003) 2.06
A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat Res (1980) 1.89
Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol (1998) 1.87
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res (1986) 1.75
Placental insufficiency and the small-for-dates baby. Am J Obstet Gynecol (1972) 1.72
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res (1997) 1.71
Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci U S A (1981) 1.70
Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70
Status and prospects for success of the endangered species act: a look at recovery plans. Science (1993) 1.68
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int (2007) 1.64
Lipoprotein(a) in cirrhosis. BMJ (1992) 1.63
Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) (1983) 1.62
An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61
Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed) (1986) 1.59
Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J Am Dent Assoc (1999) 1.58
Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J (1988) 1.57
Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.55
Mutagenesis by 9,10-anthraquinone derivatives and related compounds in Salmonella typhimurium. Mutat Res (1976) 1.51
Localisation of the vaso-motor centre. J Physiol (1923) 1.51
Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul Toxicol Pharmacol (1998) 1.51
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology (2000) 1.47
Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc Natl Acad Sci U S A (1986) 1.46
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. Osteoporos Int (2011) 1.45
Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature (1982) 1.45
Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest (1983) 1.42
The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG (2000) 1.42
Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Proc Natl Acad Sci U S A (1988) 1.41
Antibody response of mice to chemically induced tumors. Proc Natl Acad Sci U S A (1978) 1.41
Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc Natl Acad Sci U S A (1985) 1.39
On the carcinogenicity of cadmium by the oral route. Regul Toxicol Pharmacol (1992) 1.39
In vitro studies of suppressor cell function in human peripheral blood mononuclear cells. Clin Exp Immunol (1978) 1.39
Dilemmas in caries diagnosis. J Am Dent Assoc (1993) 1.39
Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal women. Osteoporos Int (2002) 1.39
Women and the GMC. Br Med J (Clin Res Ed) (1985) 1.38
Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies. J Biol Chem (1980) 1.37
Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet (1999) 1.37
A microassay for antibody binding to tumor cell surface antigens using 125I-labelled protein a from Staphylococcus aureus. J Immunol Methods (1977) 1.36
Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. Cancer Treat Rep (1984) 1.35
The burden of illness of osteoporosis in Canada. Osteoporos Int (2012) 1.34
The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun (1976) 1.34
Absence of oats toxicity in adult coeliac disease. BMJ (1996) 1.34
Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) (1985) 1.29
Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. J Immunol (1981) 1.27
Hsc70-binding peptides selected from a phage display peptide library that resemble organellar targeting sequences. J Biol Chem (1995) 1.27
The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem (1997) 1.26
Coeliac disease during the teenage period: the value of serial serum folate estimations. Gut (1974) 1.26
The part played by the ala cinerea in vaso-motor reflexes. J Physiol (1925) 1.25
Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet (1981) 1.25